|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Reck M and Rabe KF: Precision diagnosis
and treatment for advanced non-small-cell lung cancer. N Engl J
Med. 377:849–861. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Qu BL, Cai BN, Yu W, Liu F, Huang YR, Ju
ZJ, Wang XS, Ou GM and Feng LC: Radiotherapy effects on brain/bone
metastatic adenocarcinoma lung cancer and the importance of EGFR
mutation test. Neoplasma. 63:158–162. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wang Y, Yang N, Zhang Y, Li L, Han R, Zhu
M, Feng M, Chen H, Lizaso A, Qin T, et al: Effective treatment of
lung adenocarcinoma harboring EGFR-activating mutation, T790M, and
cis-C797S triple mutations by brigatinib and cetuximab combination
therapy. J Thorac Oncol. 15:1369–1375. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Marinelli D, Mazzotta M, Scalera S,
Terrenato I, Sperati F, D'Ambrosio L, Pallocca M, Corleone G,
Krasniqi E, Pizzuti L, et al: KEAP1-driven co-mutations in lung
adenocarcinoma unresponsive to immunotherapy despite high tumor
mutational burden. Ann Oncol. 31:1746–1754. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Napirei M, Wulf S, Eulitz D, Mannherz HG
and Kloeckl T: Comparative characterization of rat
deoxyribonuclease 1 (Dnase1) and murine deoxyribonuclease 1-like 3
(Dnase1l3). Biochem J. 389:355–364. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sisirak V, Sally B, D'Agati V,
Martinez-Ortiz W, Özçakar ZB, David J, Rashidfarrokhi A, Yeste A,
Panea C, Chida AS, et al: Digestion of chromatin in apoptotic cell
microparticles prevents autoimmunity. Cell. 166:88–101.
2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sjöblom T, Jones S, Wood LD, Parsons DW,
Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, et al:
The consensus coding sequences of human breast and colorectal
cancers. Science. 314:268–274. 2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Xiao Y, Yang K, Liu P, Ma D, Lei P and Liu
Q: Deoxyribonuclease 1-like 3 inhibits hepatocellular carcinoma
progression by inducing apoptosis and reprogramming glucose
metabolism. Int J Biol Sci. 18:82–95. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Guo D, Ma D, Liu P, Lan J, Liu Z and Liu
Q: DNASE1L3 arrests tumor angiogenesis by impairing the
senescence-associated secretory phenotype in response to stress.
Aging (Albany NY). 13:9874–9899. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu J, Yi J, Zhang Z, Cao D, Li L and Yao
Y: Deoxyribonuclease 1-like 3 may be a potential prognostic
biomarker associated with immune infiltration in colon cancer.
Aging (Albany NY). 13:16513–16526. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Deng Z, Xiao M, Du D, Luo N, Liu D, Liu T,
Lian D and Peng J: DNASE1L3 as a prognostic biomarker associated
with immune cell infiltration in cancer. Onco Targets Ther.
14:2003–2017. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chen J, Ding J, Huang W, Sun L, Chen J,
Liu Y, Zhan Q, Gao G, He X, Qiu G, et al: DNASE1L3 as a novel
diagnostic and prognostic biomarker for lung adenocarcinoma based
on data mining. Front Genet. 12(699242)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wu J, Liu P, Tang H, Shuang Z, Qiu Q,
Zhang L, Song C, Liu L, Xie X and Xiao X: FOXP2 promotes tumor
proliferation and metastasis by targeting GRP78 in triple-negative
breast cancer. Curr Cancer Drug Targets. 18:382–389.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Song XL, Tang Y, Lei XH, Zhao SC and Wu
ZQ: miR-618 inhibits prostate cancer migration and invasion by
targeting FOXP2. J Cancer. 8:2501–2510. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ren T, Liu C, Hou J and Shan F:
Hsa_circ_0043265 suppresses proliferation, metastasis, EMT and
promotes apoptosis in non-small cell lung cancer through
miR-25-3p/FOXP2 pathway. Onco Targets Ther. 13:3867–3880.
2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li ZY, Zhang ZZ, Bi H, Zhang QD, Zhang SJ,
Zhou L, Zhu XQ and Zhou J: Upregulated microRNA-671-3p promotes
tumor progression by suppressing forkhead box P2 expression in
non-small-cell lung cancer. Mol Med Rep. 20:3149–3159.
2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tang Z, Kang B, Li C, Chen T and Zhang Z:
GEPIA2: An enhanced web server for large-scale expression profiling
and interactive analysis. Nucleic Acids Res. 47:W556–W560.
2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhu Y, Li B, Xu G, Han C and Xing G:
lncRNA MIR4435-2HG promotes the progression of liver cancer by
upregulating B3GNT5 expression. Mol Med Rep. 25(38)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zagryazhskaya A, Gyuraszova K and
Zhivotovsky B: Cell death in cancer therapy of lung adenocarcinoma.
Int J Dev Biol. 59:119–129. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Nasim F, Sabath BF and Eapen GA: Lung
cancer. Med Clin North Am. 103:463–473. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
O'Leary K, Shia A and Schmid P: Epigenetic
regulation of EMT in non-small cell lung cancer. Curr Cancer Drug
Targets. 18:89–96. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Dongre A and Weinberg RA: New insights
into the mechanisms of epithelial-mesenchymal transition and
implications for cancer. Nat Rev Mol Cell Biol. 20:69–84.
2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tan-Garcia A, Lai F, Sheng Yeong JP, Irac
SE, Ng PY, Msallam R, Tatt Lim JC, Wai LE, Tham CYL, Choo SP, et
al: Liver fibrosis and CD206+ macrophage accumulation
are suppressed by anti-GM-CSF therapy. JHEP Rep.
2(100062)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Baek SH, Ko JH, Lee JH, Kim C, Lee H, Nam
D, Lee J, Lee SG, Yang WM, Um JY, et al: Ginkgolic acid inhibits
invasion and migration and TGF-β-induced EMT of lung cancer cells
through PI3K/Akt/mTOR inactivation. J Cell Physiol. 232:346–354.
2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wu JB, Tang YL and Liang XH: Targeting
VEGF pathway to normalize the vasculature: An emerging insight in
cancer therapy. Onco Targets Ther. 11:6901–6909. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Frezzetti D, Gallo M, Maiello MR,
D'Alessio A, Esposito C, Chicchinelli N, Normanno N and De Luca A:
VEGF as a potential target in lung cancer. Expert Opin Ther
Targets. 21:959–966. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cuiffo BG, Campagne A, Bell GW, Lembo A,
Orso F, Lien EC, Bhasin MK, Raimo M, Hanson SE, Marusyk A, et al:
MSC-regulated microRNAs converge on the transcription factor FOXP2
and promote breast cancer metastasis. Cell Stem Cell. 15:762–774.
2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yan X, Zhou H and Zhang T, Xu P, Zhang S,
Huang W, Yang L, Gu X, Ni R and Zhang T: Downregulation of FOXP2
promoter human hepatocellular carcinoma cell invasion. Tumour Biol.
36:9611–9619. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Jia WZ, Yu T, An Q, Yang H, Zhang Z, Liu X
and Xiao G: MicroRNA-190 regulates FOXP2 genes in human gastric
cancer. Onco Targets Ther. 9:3643–3651. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yu Z, Lin X, Tian M and Chang W:
microRNA-196b promotes cell migration and invasion by targeting
FOXP2 in hepatocellular carcinoma. Oncol Rep. 39:731–738.
2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Diao H, Ye Z and Qin R: miR-23a acts as an
oncogene in pancreatic carcinoma by targeting FOXP2. J Investig
Med. 66:676–683. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
He Q, Zhao L, Liu Y, Liu X, Zheng J, Yu H,
Cai H, Ma J, Liu L, Wang P, et al: circ-SHKBP1 regulates the
angiogenesis of U87 glioma-exposed endothelial cells through
miR-544a/FOXP1 and miR-379/FOXP2 pathways. Mol Ther Nucleic Acids.
10:331–348. 2018.PubMed/NCBI View Article : Google Scholar
|
